APPLIED DNA SCIENCES INC's ticker is and the CUSIP is 03815U300. A total of 31 filers reported holding APPLIED DNA SCIENCES INC in Q3 2022. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,010 | -6.2% | 101,661 | 0.0% | 0.00% | – |
| Q2 2023 | $131,143 | +14.2% | 101,661 | 0.0% | 0.00% | – |
| Q1 2023 | $114,877 | -31.9% | 101,661 | 0.0% | 0.00% | – |
| Q4 2022 | $168,758 | +48.0% | 101,661 | 0.0% | 0.00% | – |
| Q3 2022 | $114,000 | +147.8% | 101,661 | +63.7% | 0.00% | – |
| Q2 2022 | $46,000 | -74.0% | 62,120 | -25.2% | 0.00% | – |
| Q1 2022 | $177,000 | -42.9% | 83,024 | +7.7% | 0.00% | – |
| Q4 2021 | $310,000 | -25.3% | 77,078 | +0.3% | 0.00% | – |
| Q3 2021 | $415,000 | +1.5% | 76,869 | +27.3% | 0.00% | – |
| Q2 2021 | $409,000 | -36.4% | 60,376 | -32.6% | 0.00% | – |
| Q1 2021 | $643,000 | +44.5% | 89,526 | +2.5% | 0.00% | – |
| Q4 2020 | $445,000 | -30.1% | 87,319 | +6.0% | 0.00% | – |
| Q3 2020 | $637,000 | -5.9% | 82,355 | -1.9% | 0.00% | – |
| Q2 2020 | $677,000 | +132.6% | 83,969 | +15.8% | 0.00% | – |
| Q1 2020 | $291,000 | -4.3% | 72,512 | +0.0% | 0.00% | – |
| Q4 2019 | $304,000 | – | 72,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 587,232 | $710,551 | 0.78% |
| AWM Investment Company, Inc. | 808,805 | $994,830 | 0.15% |
| SABBY MANAGEMENT, LLC | 38,900 | $47,069 | 0.03% |
| Moisand Fitzgerald Tamayo, LLC | 2,000 | $2,420 | 0.00% |
| Atria Wealth Solutions, Inc. | 81,010 | $98,022 | 0.00% |
| PROVENCE WEALTH MANAGEMENT GROUP | 2,000 | $2,420 | 0.00% |
| VANGUARD GROUP INC | 523,691 | $633,666 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 49,879 | $60,354 | 0.00% |
| UBS Group AG | 803 | $972 | 0.00% |
| OSAIC HOLDINGS, INC. | 1 | $1 | 0.00% |